First results of a quantitative study of DNA adducts of melphalan in the rat by isotope dilution mass spectrometry using capillary liquid chromatography coupled to electrospray tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 19, Issue 14, 2005, Pages 1999-2004

  Van Den Driessche, Bart ^a   Esmans, Eddy L ^a   Van Der Linden, Annemie ^a   Van Dongen, Walter ^a   Schaerlaken, Evi ^a   Lemière, Filip ^a   Witters, Erwin ^a   Berneman, Zwi ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; DNA; ISOTOPES; LIQUID CHROMATOGRAPHY;

ADDUCT FORMATION; ALKYLATING AGENTS; BONE MARROW; CAPILLARY LIQUID CHROMATOGRAPHY; DNA ADDUCTS; ELECTROSPRAY TANDEM MASS SPECTROMETRY; HIGH DOSE; ISOTOPE DILUTION MASS SPECTROMETRY; MELPHALAN; QUANTITATIVE STUDY;

MASS SPECTROMETRY;

EID: 22744452112     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.2018     Document Type: Article

References (28)

1. Furner RL, Brown RK. Cancer Treatment Rep. 1980; 64: 559.
2. Gera S, Musch E, Osterheld HKO, Loos U. Cancer Chemother. Pharmacol. 1989; 23: 76.
3. Bauer GB, Povirk LF. Nucleic Acids Res. 1997; 25: 1211.
4. Bergsagel PL. Biol. Blood Marrow Transplant. 2003; 9: 2.
5. Samuels BL, Bitran JD. J. Clin. Oncol. 1995; 13: 1786.
6. Henne T, Schmahl D. Cancer Treat. Rev. 1985; 12: 77.
7. Hoes I, Lemiere F, Van Dongen W, Vanhoutte K, Esmans EL, Van Bockstaele D, Berneman Z, Deforce D, Van den Eeckhout EG. J. Chromatogr. B Biomed. Sci. Appl. 1999; 736: 43.
8. Van den Driessche B, Lemiere F, Van Dongen W, Esmans EL. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003; 785: 21.
9. Osborne MR, Lawley PD, Croftonsleigh C, Warren W. Chemico-Biol. Interactions 1995; 97: 287.
10. Belch AR, Bergsagel D, Wilson D, Klimo P, White D, Zee B, Johnston D. Blood 1997; 90: 1584.
11. Chiarelli MP, Lay JO. Mass Spectrom. Rev. 1992; 11: 447.
12. Frenkel K, Klein CB. J. Chromatogr. Biomed. Appl. 1993; 618: 289.
13. Esmans EL, Broes D, Hoes I, Lemière F, Vanhoutte K. J. Chromatogr. A 1998; 794: 109.
14. Hemminki K, Forsti A, Mustonen R, Savela K. J. Cancer Res. Clin. Oncol. 1986; 112: 181.
15. Hemminki K. Carcinogenesis 1993; 14: 2007.
16. Randerath K, Randerath E. Drug Metab. Rev. 1994; 26: 67.
17. Tilby MJ, Styles JM, Dean CJ. Cancer Res. 1987; 47: 1542.
18. Routledge MN, Garner RC, Kirschvolders M. Mutagenesis 1992; 7: 329.
19. Hemminki K, Koskinen M, Rajaniemi H, Zhao C. Regul. Toxicol. Pharmacol. 2000; 32: 264.
20. Van den Driessche B, Lemière F, Van Dongen W, Van Der Linden A, Esmans EL. J. Mass Spectrom. 2004; 39: 29.
21. Hansson J, Lewensohn R, Ringborg U, Nilsson B. Cancer Res. 1987; 47: 2631.
22. Hansson J, Edgren M, Ehrsson H, Lewensohn R, Ringborg U. Anticancer Res. 1987; 7: 97.
23. Ahmed AE, Hsu TF, Elazhary RA, Moawad H, Farrish HH, Costanzi J. Cancer Chemother. Pharmacol. 1982; 8: 271.
24. McCoy GDE. In Methods in Enzymology, vol. CXCIII, 1990; chap XLII.
25. Doerge DR, Churchwell MI, Fang JL, Beland FA. Chem. Res. Toxicol. 2000; 13: 1259.
26. Paehler A, Richoz J, Soglia J, Vouros P, Turesky RJ. Chem. Res. Toxicol. 2002; 15: 551.
27. Churchwell MI, Beland FA, Doerge DR. Chem. Res. Toxicol. 2002; 15: 1295.
28. Loureiro APM, Marques SA, Garcia CCM, Di Mascio P, Medeiros MHG. Chem. Res. Toxicol. 2002; 15: 1302.